July 25, 2016 10:11 PM ET

Biotechnology

Company Overview of EPIRUS Biopharmaceuticals, Inc.

Executive Profile

Mark H. N. Corrigan M.D.

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 8 different industries.

See Board Relationships
58$92,796

Background

Dr. Mark H. N. Corrigan, M.D. served as the Chief Executive Officer and President of Zalicus Inc. from January 2010 to June 2014. Dr. Corrigan is a seasoned life sciences executive. Dr. Corrigan joined the specialty pharmaceutical company Sepracor Inc. in 2003. He served as an Executive Vice President of Research & Development of Sunovion Pharmaceuticals Inc. (formerly, Sepracor Inc.) from April 21, 2003 to December 2009. He has over 20 years of experience in treating ...

Corporate Headquarters

699 Boylston Street
Boston, Massachusetts 02116

United States

Phone: 617-600-3497
Fax: --

Board Members Memberships

2009-Present
Chairman
2015-Present
Director, Chairman of Corporate Governance & Nomination Committee and Member of Compensation Committee
2015-Present
Director and Chairman of Compensation Committee
2015-Present
Director
2015-Present
Director

Education

BA
University of Virginia
MD
University of Virginia

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$82,827
Unexercisable Options$4,500
Total Number of Options$87,327

Total Compensation

Total Annual Cash Compensation$60,000
Total Calculated Compensation$92,796
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EPIRUS Biopharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.